4.1 Editorial Material

Clinical trials of CD19-targeted CAR-modified T cell therapy; a complex and varied landscape

Journal

EXPERT REVIEW OF HEMATOLOGY
Volume 9, Issue 8, Pages 719-721

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/17474086.2016.1203251

Keywords

Chimeric antigen receptor; immunotherapy; T cells; acute lymphoblastic leukemia; non-Hodgkin lymphoma; chronic lymphocytic leukemia; cellular therapy

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available